Carthera kicks off pivotal trial with blood-brain-barrier opening device

Carthera has enrolled the first patient in a pivotal trial evaluating its low-intensity pulsed ultrasound (LIPUS)-based technology which helps drugs reach the brain in higher concentrations.

The French medtech company is initially testing its SonoCloud device in patients receiving chemotherapy for glioblastoma, the most common type of brain cancer.